Loading Results
We have updated our Online Services Terms of Use and Privacy Policy. See our Cookies Notice for information concerning our use of cookies and similar technologies. By using this website or clicking “I ACCEPT”, you consent to our Online Services Terms of Use.

Patient-Centered Customized Psychosocial Adherence Enhancement Intervention Schizophrenia (CAE-S) Study

Prospective 12-week randomized controlled trial (RCT) of remotely- delivered Customized Adherence Enhancement for poorly adherent individuals with schizophrenia (CAE-S) vs Enhanced Treatment as Usual (eTAU)

caring hands
Age: 18+ years
Sex at Birth: All
Type: Interventional study
Condition: Schizophrenia
Healthy Participants: No
Location: UH Cleveland Medical Center

Learn More About This Research Study

To learn more about this study please complete the online form below.

Study Purpose

The purpose of the study is to see if a behavioral intervention helps people who have schizophrenia take their medication more consistently and better manage their symptoms. Participating is the study lasts about 3 months and includes 3 study visits and 6 educational session visits. All visits can be done via video conferencing and compensation is provided.

Who Can Participate

Participants 18 years or older diagnosed with schizophrenia may be eligible for this study.

Request More Information

Please complete the form below to be contacted by a study representative and learn more about this study,

I'm not a robot

  • STUDYID 2022-01101